Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: The oral glucose tolerance test (OGTT) is a cumbersome test that is time consuming, labour intensive and often poorly tolerated by pregnant women. To date, glycosylated haemoglobin (HbA1c) is the most accepted measure of chronic glycaemia outside of pregnancy. HbA1c is an uncomplicated test, less time consuming, does not require any specific patient preparation and is considered straightforward compared with the OGTT. Therefore, we prospectively tested the utility of the HbA1c when used as a screening tool in pregnancy for gestational diabetes mellitus (GDM). SETTINGS: Primary health care. Single tertiary referral centre, Tasmania, Australia. PARTICIPANTS: A direct comparison between HbA1c levels and the OGTT results in pregnant women, tested concurrently at the 24-28 gestational week, was undertaken. A full profile of 480 pregnant women during the period from September 2012 to July 2014 was completed. Median and mean age of participants was 29 years (range 18-47 years). INTERVENTIONS: A simultaneous prospective assessment of HbA1c versus standard OGTT in a cohort of consecutive pregnant women presenting to our institute was performed. RESULTS: The number of women who had GDM according to OGTT criteria was 57, representing 11.9% of the evaluated 480 pregnant women. Using a cut-off value for HbA1c at 5.1% (32 mmol/mol) for detecting GDM showed sensitivity of 61% and specificity of 68% with negative predictive value (NPV) of 93%, versus sensitivity of 27% and specificity of 95% with NPV of 91% when using HbA1c cut-off value of 5.4% (36 mmol/mol). CONCLUSIONS: Our results suggest that pregnant women with an HbA1c of≥5.4% (36 mmol/mol) should proceed with an OGTT. This may result in a significant reduction in the burden of testing on both patients and testing facility staff and resources. Further investigations are required to integrate and optimise the HbA1c as a single, non-fasting, screening tool for GDM. TRIAL REGISTRATION NUMBER: ACTRN12611000739910.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The use of A1C at 24 -28 weeks of gestation as a screening test for GDM does not function as well as the GLT (224).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [224]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The use of A1C at 24-28 weeks of gestation as a screening test for GDM does not function as well as the GLT (206).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [206]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Adiponectin Levels and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
Li, S., Shin, H. J., Ding, E. L., & van Dam, R. M. (2009) · JAMA · doi:10.1001/jama.2009.976 · Cited by 991
Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus
Butte, N. F. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1256s · Cited by 826
Pregnancy Outcomes in Women With Gestational Diabetes Compared With the General Obstetric Population
Casey, B. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00542-5 · Cited by 437 · cited 1×
“INTRODUCTION Pregnancies affected by gestational diabetes mellitus (GDM) are at risk of developing a number of serious obstetric complications such as fetal growth abnormalities, shoulder dystocia, birth injury, prematurity and increased Caesarean section rate, as well as having long-term implications for the wellbein…”
BackgroundShort-term variability in measures of glycemia and implications for the classification of diabetes
Selvin, E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1545 · Cited by 402
HbA1c levels are significantly lower in early and late pregnancy
Nielsen, L. R., Ekbom, P., Damm, P., Glümer, C., Frandsen, M. M., Jensen, D. M., & Mathiesen, E. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1200 · Cited by 331
Drug-Induced Disorders of Glucose Tolerance
Pandit, M. K., Burke, J., Gustafson, A. B., Minocha, A., & Peiris, A. N. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00008 · Cited by 239
Khalafallah, A. A., & Dennis, A. E. (2012) · Journal of Pregnancy · doi:10.1155/2012/630519 · Cited by 164
Self-citationKhalafallah, A., Dennis, A., Bates, J., Bates, G., Robertson, I. K., Smith, L., Ball, M. J., Seaton, D., Brain, T., & Rasko, J. E. J. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02251.x · Cited by 128
Self-citationUtility of HbA1c for diagnosis of gestational diabetes mellitus
Rajput, R., YogeshYadav, Rajput, M., & Nanda, S. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.02.018 · Cited by 127
A history of HbA 1c through Clinical Chemistry and Laboratory Medicine
Gillery, P. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2012-0548 · Cited by 98 · cited 1×
“Previously, HbA1c results could not be compared between one laboratory and another let alone one country to another.(24) However, since international standardisation of the assay, this is no longer the case.”
Glycated hemoglobin (HbA1c): old dogmas, a new perspective?
Lippi, G., & Targher, G. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.144 · Cited by 91 · cited 15×
“To our knowledge, there are no published data comparing the 75 g two-step OGTT as per current guidelines with HbA1c in establishing the diagnosis of GDM.”
BackgroundInfluentialKhalafallah, A. A., Dennis, A. E., Ogden, K., Robertson, I., Charlton, R. H., Bellette, J. M., Shady, J. L., Blesingk, N., & Ball, M. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-000998 · Cited by 83
Self-citationGestational diabetes: a reappraisal of HBA1c as a screening test
Agarwal, M. M., Dhatt, G. S., Punnose, J., & Koster, G. (2005) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1080/j.0001-6349.2005.00650.x · Cited by 77
A1C in Gestational Diabetes Mellitus in Asian Indian Women
Balaji, V., Madhuri, B. S., Ashalatha, S., Sheela, S., S, S., & Seshiah, V. (2007) · Diabetes Care · doi:10.2337/dc06-2329 · Cited by 73
Gestational diabetes screening of a multiethnic, high-risk population using glycated proteins
Agarwal, M., Hughes, P. F., Punnose, J., Ezimokhai, M., & Thomas, L. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00206-0 · Cited by 67
Trimester-specific reference intervals for haemoglobin A1c (HbA1c) in pregnancy
O’Connor, C., O’Shea, P. M., Owens, L. A., Carmody, L., Avalos, G., Nestor, L., Lydon, K., & Dunne, F. (2012) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2011.397 · Cited by 63 · cited 1×
“and NPV of 91% in detecting GDM, in line with the reference range for pregnancy reported by other studies.(17) 25 Using a cut-off value of HbA1c 5.”
ResultTesting for Gestational Diabetes Mellitus in Australia
Nankervis, A., McIntyre, H. D., Moses, R. G., Ross, G. P., & Callaway, L. K. (2013) · Diabetes Care · doi:10.2337/dc12-2345 · Cited by 63 · cited 1×
“Australian population from 6–8% to 13%.(2) The guidelines recommend a 75 g oral glucose tolerance test (OGTT) at 24–28 weeks gestation for all pregnant women.”
BackgroundGlycohemoglobin A1c: A promising screening tool in gestational diabetes mellitus
Aldasouqi, S. A., Solomon, D., Bokhari, S., Khan, P. M., Muneera, S., & Gossain, V. V. (2008) · International Journal of Diabetes in Developing Countries · doi:10.4103/0973-3930.45271 · Cited by 32
Diagnostic tests: Glycated haemoglobin for the diagnosis of diabetes
dʼEmden, M. C. (2014) · Australian Prescriber · doi:10.18773/austprescr.2014.037 · Cited by 29 · cited 2×
“It is thought to vary by up to 14% in a third of cases.(3) While guidelines are in place, the glucose threshold values for diagnosis and methods of testing for GDM vary greatly from one institution to another.”
Hartland, A. J., Smith, J. M., Clark, P. M. S., Webber, J., Chowdhury, T., & Dunne, F. (1999) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/000456329903600218 · Cited by 24 · cited 1×
“tically powered to detect such differences as other trials demonstrated.(23) The sex of the baby, complications of pregnancy or type”
BackgroundPollak, A. J., Brehm, R., Havelec, L., Lübec, G., Malamitsi‐Puchner, A., Simbrunner, G., & Widness, J. A. (2009) · Biology of the Neonate · doi:10.1159/000241481 · Cited by 23
Haemoglobin A1c levels in normal and diabetic pregnancies
Griffiths, R. J., Vinall, P., Stickland, M. H., & Wales, J. K. (1987) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(87)90018-9 · Cited by 20
Tian, Q., Xuan, C., Wang, H., Zhao, J., Yu, W.-L., Gao, G., Zhang, B., & Lun, L. (2013) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2013.0099 · Cited by 17 · cited 15×
“To our knowledge, there are no published data comparing the 75 g two-step OGTT as per current guidelines with HbA1c in establishing the diagnosis of GDM.”
MethodInfluentialComprehensive picture of rural women's needs in maternity care in Tasmania, Australia
Hoang, H., & Lê, Q. (2013) · Australian Journal of Rural Health · doi:10.1111/ajr.12043 · Cited by 15 · cited 1×
“locations, potentially disadvantaging an already vulnerable cohort of women.(4) The need for a simpler, more universally acceptable”
BackgroundHbA1c and the diagnosis of gestational diabetes mellitus—A test whose time has not yet come
Moses, R. G. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.05.016 · Cited by 10
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
“A systematic review for the U.S. Preventive Services Task Force compared GLT cutoffs of 130 mg/dL (7.2 mmol/L) and 140 mg/dL (7.8 mmol/L) (241).”
MethodInfluential2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s002 · Cited by 3,187
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
“The American College of Obstetricians and Gynecologists (ACOG) recommends any of the commonly used thresholds of 130, 135, or 140 mg/dL for the 1-h 50-g GLT (69).”
MethodInfluential2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
Metadata
- Authors
- Khalafallah, A., Phuah, E., Al-Barazan, A. M., Nikakis, I., Radford, A., Clarkson, W., Trevett, C., Brain, T., Gebski, V., & Corbould, A.
- Affiliations
- University of Tasmania (AU)
- Launceston General Hospital (AU)
- National Health and Medical Research Council (AU)
- Corresponding author
- Khalafallah, Alhossain
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2016-04
- Volume
- 6
- Issue
- 4
- Pages
- e011059
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC4823451
- OpenAlex
- W2337854077
- Cited by
- 86
- References
- 31
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 6 · 2022: 12 · 2021: 7 · 2020: 12 · 2019: 11 · 2018: 12 · 2017: 9 · 2016: 2
- FWCI
- 14.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by-nc)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- glycosylated haemoglobin, HbA1c, gestational diabetes mellitus, gestational diabetes screening, oral glucose tolerance test, diagnostic accuracy, cut-off values, primary care
- MeSH terms
- Adolescent, Adult, Australia, Blood Glucose, Female, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Mass Screening, Middle Aged, Pregnancy, Primary Health Care, Prospective Studies, Biomarkers, Diabetes, Gestational, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.